Skip to main content
Journal cover image

Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation.

Publication ,  Journal Article
Dharmarajan, H; Choby, G; Abi Hachem, R; Kuan, EC; Levine, CG; Sanusi, O; Schuman, T; Tang, D; Yim, M; Geltzeiler, M
Published in: Int Forum Allergy Rhinol
May 2024

Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology. Approximately half of patients who undergo unilateral resection may have residual olfaction even with adjuvant unilateral radiation. Early data suggest favorable disease-free survival and overall survival for patients who underwent the unilateral approach; however, larger sample studies are needed to confirm comparability to bilateral resections regarding oncologic outcomes.

Duke Scholars

Published In

Int Forum Allergy Rhinol

DOI

EISSN

2042-6984

Publication Date

May 2024

Volume

14

Issue

5

Start / End Page

881 / 886

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smell
  • Nose Neoplasms
  • Nasal Cavity
  • Humans
  • Esthesioneuroblastoma, Olfactory
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dharmarajan, H., Choby, G., Abi Hachem, R., Kuan, E. C., Levine, C. G., Sanusi, O., … Geltzeiler, M. (2024). Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation. Int Forum Allergy Rhinol, 14(5), 881–886. https://doi.org/10.1002/alr.23345
Dharmarajan, Harish, Garret Choby, Ralph Abi Hachem, Edward C. Kuan, Corinna G. Levine, Olabisi Sanusi, Theodore Schuman, Dennis Tang, Michael Yim, and Mathew Geltzeiler. “Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation.Int Forum Allergy Rhinol 14, no. 5 (May 2024): 881–86. https://doi.org/10.1002/alr.23345.
Dharmarajan H, Choby G, Abi Hachem R, Kuan EC, Levine CG, Sanusi O, et al. Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation. Int Forum Allergy Rhinol. 2024 May;14(5):881–6.
Dharmarajan, Harish, et al. “Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation.Int Forum Allergy Rhinol, vol. 14, no. 5, May 2024, pp. 881–86. Pubmed, doi:10.1002/alr.23345.
Dharmarajan H, Choby G, Abi Hachem R, Kuan EC, Levine CG, Sanusi O, Schuman T, Tang D, Yim M, Geltzeiler M. Treatment of unilateral olfactory neuroblastoma: Appropriate extent of surgical resection and potential for olfactory preservation. Int Forum Allergy Rhinol. 2024 May;14(5):881–886.
Journal cover image

Published In

Int Forum Allergy Rhinol

DOI

EISSN

2042-6984

Publication Date

May 2024

Volume

14

Issue

5

Start / End Page

881 / 886

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Smell
  • Nose Neoplasms
  • Nasal Cavity
  • Humans
  • Esthesioneuroblastoma, Olfactory
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1107 Immunology